CAS 862507-23-1

LY2228820

CAS: 862507-23-1

Fórmula: C₂₆H₃₇FN₆O₆S₂

Pureza: 98%

Forma y color: Solid

Peso molecular: 612.7370

Ref: IN-DA00GU43

LY2228820

CAS: 862507-23-1

LY2228820

Fórmula: C₂₄H₂₉FN₆·2CH₃SO₃H

Forma y color: Solid-Powder

Peso molecular: 612.73698

Ref: 54-BISN0222

Ralimetinib dimesylate

CAS: 862507-23-1

Ralimetinib dimesylate

Fórmula: C₂₄H₂₉FN₆·2CH₄O₃S

Pureza: ≥98%

Peso molecular: 612.74

Ref: 54-BUP04719

Ralimetinib dimesylate

CAS: 862507-23-1

5-(2-(tert-Butyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl)-3-neopentyl-3H-imidazo[4,5-b]pyridin-2-amine dimethanesulfonate

Fórmula: C₂₆H₃₇FN₆O₆S₂

Pureza: 98%

Peso molecular: 612.74

Ref: IN-DG306011

Ralimetinib dimesylate

CAS: 862507-23-1

Ralimetinib dimesylate (LY2228820 dimesylate) is a orally available, p38 MAPK inhibitor with potential anti-inflammatory and antineoplastic activities.

Fórmula: C₂₄H₂₉FN₆·2CH₄O₃S

Pureza: 98% - 99.38%

Forma y color: White Solid

Peso molecular: 612.74

Ref: TM-T6047

LY 2228820

Producto controlado

CAS: 862507-23-1

Fórmula: C₂₄H₂₉FN₆

Forma y color: Neat

Peso molecular: 420.526

Ref: TR-L486500

LY 2228820 dimesylate

CAS: 862507-23-1

Inhibitor of p38 mitogen-activated protein kinase

Fórmula: C₂₆H₃₇FN₆O₆S₂

Pureza: Min. 95%

Peso molecular: 612.74 g/mol

Ref: 3D-FL24961